Cargando…
Daclatasvir and Asunaprevir Combination Therapy-induced Hepatitis and Cholecystitis with Coagulation Disorder due to Hypersensitivity Reactions
A 70-year-old woman with chronic hepatitis C was admitted to our hospital due to liver injury, cholecystitis, and disseminated intravascular coagulation with a fever and skin rash. She had been on a combination regimen of daclatasvir and asunaprevir for 2 weeks of a 24-week regimen. Because of the s...
Autores principales: | Miyashima, Yuichi, Honma, Yuichi, Miyagawa, Koichiro, Oe, Shinji, Senju, Michio, Shibata, Michihiko, Hiura, Masaaki, Abe, Shintaro, Harada, Masaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283959/ https://www.ncbi.nlm.nih.gov/pubmed/27980259 |
Ejemplares similares
-
Severe Alcoholic Hepatitis Effectively Treated with Vitamin E as an Add-on to Corticosteroids
por: Miyashima, Yuichi, et al.
Publicado: (2017) -
Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency
por: Koya, Yudai, et al.
Publicado: (2018) -
Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma
por: Muraishi, Junichi, et al.
Publicado: (2017) -
Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma
por: Hayashi, Tsuguru, et al.
Publicado: (2020) -
C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib
por: Hayashi, Tsuguru, et al.
Publicado: (2020)